Evidence map›Paper›PMID 26069504›Full record

ArticleCancer nanotechnology

Green synthesis of gold nanoparticles and their anticancer activity.

Ravi Geetha, Thirunavukkarasu Ashokkumar, Selvaraj Tamilselvan, Kasivelu Govindaraju, Mohamed Sadiq, Ganesan Singaravelu

Abstract read
In one paragraph

Article in Cancer nanotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Eco-friendly Synthesis ofPharmaceutical nanotechnology · 2025
    Review
  12. Harnessing the Therapeutic Potential ofCurrent drug discovery technologies · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ravi GeethaNanoscience Division, Department of Zoology, Thiruvalluvar University, Vellore, 632 115 India.
Thirunavukkarasu AshokkumarNanoscience Division, Department of Zoology, Thiruvalluvar University, Vellore, 632 115 India.
Selvaraj TamilselvanNanoscience Division, Department of Zoology, Thiruvalluvar University, Vellore, 632 115 India.
Kasivelu GovindarajuCentre for Ocean Research, Sathyabama University, Chennai, 600 119 India.
Mohamed SadiqDepartment of Biochemistry, Adhiparasakthi College of Arts and Science, Kalavai, Tamilnadu India.
Ganesan SingaraveluNanoscience Division, Department of Zoology, Thiruvalluvar University, Vellore, 632 115 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the nano revolution unfolds, it is imperative to integrate nanoscience and medicine. The secret gleaned from nature have led to the generation of biogenic technologies for the fabrication of advanced nanomaterials. Present investigation discloses the gold nanoparticles biosynthesizing capability of the flower of pharmacologically important tree

Indexed as

AnticancerCouroupita guianensisDNA fragmentationGold nanoparticles

Identifiers

PMID26069504
PMCPMC4451866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.